share_log

騰盛博藥-B：2023被動外國投資公司狀態之通知

BRII-B: Notification of 2023 PFIC status

香港交易所 ·  Apr 12 10:45
Summary by Moomoo AI
騰盛博藥生物科技有限公司（腾盛博药-B）於2024年4月12日發布通知，告知美國股東其及其全資及72.8%持股子公司於2023年度被認定為被動外國投資公司（PFIC）。公司提供PFIC年度資料聲明，供美國股東選擇將相關公司視為合資格選擇基金（QEF）。美國股東若選擇QEF，須將相關公司的普通盈利及淨資本收益計入年度所得。公司強調，此資訊僅用於協助股東計算，不構成稅務建議，並建議股東就稅務後果諮詢專業顧問。該通知還包含了填寫IRS表格8621的相關指引及相關公司的財務資料。
騰盛博藥生物科技有限公司（腾盛博药-B）於2024年4月12日發布通知，告知美國股東其及其全資及72.8%持股子公司於2023年度被認定為被動外國投資公司（PFIC）。公司提供PFIC年度資料聲明，供美國股東選擇將相關公司視為合資格選擇基金（QEF）。美國股東若選擇QEF，須將相關公司的普通盈利及淨資本收益計入年度所得。公司強調，此資訊僅用於協助股東計算，不構成稅務建議，並建議股東就稅務後果諮詢專業顧問。該通知還包含了填寫IRS表格8621的相關指引及相關公司的財務資料。
TENSHENGBO PHARMACEUTICAL BIOTECHNOLOGY CO., LTD. (TENSHENGBO PHARMACEUTICAL-B) ISSUED A NOTICE ON APRIL 12, 2024, INFORMING U.S. SHAREHOLDERS THAT IT AND ITS WHOLLY OWNED SUBSIDIARIES AND 72.8% SHAREHOLDINGS ARE RECOGNIZED AS PASSIVE FOREIGN INVESTMENT COMPANIES (PFIC) IN 2023. The Company provides the PFIC Annual Information Statement for U.S. shareholders to elect to treat the relevant company as an Eligible Selection Fund (QEF). If U.S. shareholders elect QEF, they will be required to factor the ordinary profit and net capital gains of the respective company into annual income. THE COMPANY EMPHASIZES THAT THIS INFORMATION IS USED ONLY TO ASSIST SHAREHOLDERS IN CALCULATIONS, DOES NOT CONSTITUTE TAX ADVICE AND ADVISES SHAREHOLDERS TO CONSULT WITH PROFESSIONAL ADVISERS ON TAX CONSEQUENCES. The notice also includes guidance on filling out IRS Form 8621 and financial information for the companies involved.
TENSHENGBO PHARMACEUTICAL BIOTECHNOLOGY CO., LTD. (TENSHENGBO PHARMACEUTICAL-B) ISSUED A NOTICE ON APRIL 12, 2024, INFORMING U.S. SHAREHOLDERS THAT IT AND ITS WHOLLY OWNED SUBSIDIARIES AND 72.8% SHAREHOLDINGS ARE RECOGNIZED AS PASSIVE FOREIGN INVESTMENT COMPANIES (PFIC) IN 2023. The Company provides the PFIC Annual Information Statement for U.S. shareholders to elect to treat the relevant company as an Eligible Selection Fund (QEF). If U.S. shareholders elect QEF, they will be required to factor the ordinary profit and net capital gains of the respective company into annual income. THE COMPANY EMPHASIZES THAT THIS INFORMATION IS USED ONLY TO ASSIST SHAREHOLDERS IN CALCULATIONS, DOES NOT CONSTITUTE TAX ADVICE AND ADVISES SHAREHOLDERS TO CONSULT WITH PROFESSIONAL ADVISERS ON TAX CONSEQUENCES. The notice also includes guidance on filling out IRS Form 8621 and financial information for the companies involved.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more